VL1

Gedatolisib


Toggle HydrogenToggle Labels

Chemical Component Summary

NameGedatolisib
SynonymsN-{4-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]phenyl}-N'-{4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl}urea
Identifiers1-[4-[4-(dimethylamino)piperidin-1-yl]carbonylphenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
FormulaC32 H41 N9 O4
Molecular Weight615.726
TypeNON-POLYMER
Isomeric SMILESCN(C)C1CCN(CC1)C(=O)c2ccc(cc2)NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6
InChIInChI=1S/C32H41N9O4/c1-38(2)27-11-13-39(14-12-27)29(42)24-5-9-26(10-6-24)34-32(43)33-25-7-3-23(4-8-25)28-35-30(40-15-19-44-20-16-40)37-31(36-28)41-17-21-45-22-18-41/h3-10,27H,11-22H2,1-2H3,(H2,33,34,43)
InChIKeyDWZAEMINVBZMHQ-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count86
Chiral Atom Count0
Bond Count91
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB11896 
NameGedatolisib
Groups investigational
DescriptionGedatolisib has been used in trials studying the basic science and treatment of Neoplasm, Ovary Cancer, Breast Cancer, Advanced Cancer, and Endometrial Cancer, among others.
SynonymsGedatolisib
Categories
  • Enzyme Inhibitors
  • Oxazines
  • Protein Kinase Inhibitors
CAS number1197160-78-3

Related Resource References

Resource NameReference
Pharos CHEMBL592445
PubChem 44516953
ChEMBL CHEMBL592445